↓ Skip to main content

Dove Medical Press

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer

Overview of attention for article published in Cancer Management and Research, March 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
21 Mendeley
Title
Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
Published in
Cancer Management and Research, March 2012
DOI 10.2147/cmar.s29267
Pubmed ID
Authors

Enrico Aitini, Anna Rossi, Patrizia Morselli, Beatrice Vivorio, Alessandra Bruschi, Chiara Bottura, Giorgio L Colombo

Abstract

Colorectal cancer is one of the most frequent and lethal cancers. The aim of this study was to analyze the costs relating to treatment of colorectal cancer between Xelox and Folfox-4 at a regional level according to the clinical experience at an Italian hospital in Lombardy.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 1 5%
Unknown 20 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 29%
Student > Bachelor 3 14%
Other 3 14%
Researcher 2 10%
Student > Postgraduate 2 10%
Other 3 14%
Unknown 2 10%
Readers by discipline Count As %
Medicine and Dentistry 11 52%
Agricultural and Biological Sciences 2 10%
Biochemistry, Genetics and Molecular Biology 1 5%
Business, Management and Accounting 1 5%
Nursing and Health Professions 1 5%
Other 2 10%
Unknown 3 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2012.
All research outputs
#20,553,433
of 25,257,066 outputs
Outputs from Cancer Management and Research
#1,124
of 2,064 outputs
Outputs of similar age
#126,914
of 161,552 outputs
Outputs of similar age from Cancer Management and Research
#9
of 9 outputs
Altmetric has tracked 25,257,066 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,064 research outputs from this source. They receive a mean Attention Score of 3.5. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,552 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.